We are live on
!
Find out more
CT
Cambridge Trust Portfolio holdings
AUM
$2.64B
Turnover
15.41%
1-Year Est. Return
28.73%
This Fund
S&P 500
This Quarter
Est. Return
+0.68%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$2.65B
AUM Growth
-$6.46M
(-0.24%)
Cap. Flow
-$6.34M
Cap. Flow
% of AUM
-0.24%
Top 10 Holdings %
Top 10 Hldgs %
27.59%
Holding
284
New
10
Increased
82
Reduced
124
Closed
13
Avg Time Held
4.4
years
Top 10 Avg Time Held
2.7
years
Top 20 Avg Time Held
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$16.4M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.62M |
| 3 |
Genuine Parts
GPC
|
+$2.32M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$2.21M |
| 5 |
Verisk Analytics
VRSK
|
+$2.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$17M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$12.6M |
| 3 |
Clorox
CLX
|
+$4.08M |
| 4 |
Automatic Data Processing
ADP
|
+$1.99M |
| 5 |
Waste Management
WM
|
+$1.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.89% |
| 2 | Financials | 18.17% |
| 3 | Miscellaneous | 16.16% |
| 4 | Healthcare | 10.44% |
| 5 | Consumer Discretionary | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
RDS.A
251
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $237K | 0.01% |
5,304
+4
| +0.1% | +$161 |
2021 Q1
2 quarters
|
|
252
DELISTED
AvalonBay Communities
AVB
| $234K | 0.01% |
1,058
| – | – |
2021 Q1
2 quarters
|
|
253
Integra LifeSciences
IART
$1.03B
| $234K | 0.01% |
3,424
-417
| -11% | -$29.5K |
2015 Q3
24 quarters
|
|
254
Dover
DOV
$26.4B
| $232K | 0.01% |
1,494
| – | – |
2021 Q1
2 quarters
|
|
255
ON Semiconductor
ON
$28B
| $230K | 0.01% |
+5,019
| New | +$214K |
2021 Q3
0 quarters
|
|
256
Wolfspeed
WOLF
$1.23B
| $228K | 0.01% |
2,820
| – | – |
2020 Q4
3 quarters
|
|
257
Schwab US Large- Cap ETF
SCHX
$73.7B
| $227K | 0.01% |
13,086
| – | – |
2020 Q4
3 quarters
|
|
258
Citigroup
C
$208B
| $226K | 0.01% |
3,215
| – | – |
2021 Q1
2 quarters
|
|
259
Crane NXT
CXT
$3.15B
| $222K | 0.01% |
6,731
| – | – |
2021 Q1
2 quarters
|
|
260
Zimmer Biomet
ZBH
$18.1B
| $215K | 0.01% |
1,512
| – | – |
2020 Q2
5 quarters
|
|
261
Canadian National Railway
CNI
$73.6B
| $213K | 0.01% |
+1,845
| New | +$204K |
2021 Q3
0 quarters
|
|
262
Boeing
BA
$150B
| $212K | 0.01% |
963
+71
| +8% | +$15.8K |
2021 Q2
1 quarter
|
|
263
Moderna
MRNA
$87B
| $210K | 0.01% |
+545
| New | +$201K |
2021 Q3
0 quarters
|
|
264
Vanguard Morningstar Growth ETF
VUG
$227B
| $208K | 0.01% |
4,296
| – | – |
2021 Q2
1 quarter
|
|
265
Omnicom Group
OMC
$22.1B
| $207K | 0.01% |
2,860
| – | – |
2021 Q1
2 quarters
|
|
266
Manulife Financial
MFC
$73.4B
| $205K | 0.01% |
10,641
| – | – |
2021 Q1
2 quarters
|
|
267
BlackRock MuniYield Quality Fund
MQY
$1.55B
| $194K | 0.01% |
11,979
| – | – |
2021 Q2
1 quarter
|
|
268
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$822M
| $187K | 0.01% |
50,000
+25,000
| +100% | +$96.8K |
2021 Q2
1 quarter
|
|
|
CMPI
269
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| $98K | ﹤0.01% |
24,609
| – | – |
2021 Q1
2 quarters
|
|
270
SemiLEDS
LEDS
$16.1M
| $96K | ﹤0.01% |
12,260
| – | – |
2019 Q4
7 quarters
|
|
271
Abeona Therapeutics
ABEO
$253M
| $73K | ﹤0.01% |
2,617
| – | – |
2015 Q2
25 quarters
|
|
272
Cummins
CMI
$73.1B
| – | – |
-860
| Closed | -$210K | – |
|
273
FedEx
FDX
$69.5B
| – | – |
-813
| Closed | -$243K | – |
|
274
Keysight
KEYS
$56.4B
| – | – |
-1,338
| Closed | -$207K | – |
|
275
Kimberly-Clark
KMB
$35.1B
| – | – |
-1,600
| Closed | -$214K | – |
|
Similar funds
ZCM
CQS
SCM
AFIMH
DA
Cambridge Trust's Q3 2021 Portfolio in Review
As of Q3 2021, Cambridge Trust held 284 positions worth $2.65B, down 0.24% from $2.66B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Cambridge Trust's Q3 2021 filing shows 10 new, 82 increased, 124 reduced and 13 closed positions. Its largest new stake was iShares ESG Aware US Aggregate Bond ETF: 23,850 shares worth $1.31M. The largest sale was Alibaba, an estimated $17M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Miscellaneous.
- Cambridge Trust's largest Q3 2021 buy was iShares ESG Aware US Aggregate Bond ETF: 23,850 shares worth $1.31M.
- Cambridge Trust added most to Novartis in Q3 2021, an estimated $16.4M increase.
- Cambridge Trust's biggest Q3 2021 reduction was Alibaba, cutting an estimated $17M.
- Cambridge Trust fully exited Organon & Co in Q3 2021, selling an estimated $349K.
- Cambridge Trust's ten largest holdings make up 28% of its $2.65B portfolio in Q3 2021.
- Cambridge Trust opened 10 new positions and closed 13 in Q3 2021.
- Cambridge Trust's portfolio value fell 0.24% quarter-over-quarter to $2.65B.
Based on Cambridge Trust's 13F filing for Q3 2021, filed 16 Nov 2021.